Yearly Archives: 2016

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It

Each quarter, the Best Practices Digital Marketing Consortium convenes a virtual roundtable meeting to bring together life-sciences executives to discuss successes, failures and new opportunities to use digital marketing to transform the bio-pharma customer engagement model. Our most recent meeting,

In the bio-pharmaceutical industry, it is no secret that different regions of the world have diverse regulatory and cultural environments. What is less apparent is that given these regional regulatory and cultural differences, pharmaceutical companies can have an effective global

Mobile tools have become an integral part of digital marketing for the bio-pharmaceutical industry. Health care companies have turned to mobile applications in particular to provide resources, services and critical references for customers. According to our latest benchmark research: Digital

In the pharmaceutical sector, disease state awareness campaigns are one of the few ways to reach patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch. While

Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and ultimately what

Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA) organizations from large and complex companies

In a sector as fast-changing as biopharmaceuticals, it’s important to look beyond today’s hot topics to identify the long-term factors which are really driving change in the industry. From a list that could include a hundred headline-grabbing trends, we’ve pinned